JG
LENZ

Jain Global’s LENZ Therapeutics LENZ Stock Holding History

Jain Global’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Buy
48,190
+10,998
+30% +$88.6K ﹤0.01% 1424
2026
Q1 		$340K Buy
+37,192
New +$522K ﹤0.01% 1000

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Jain Global's LENZ Position: Q2 2026 in Review

Jain Global increased its LENZ Therapeutics (LENZ) stake by 30% in Q2 2026, buying an estimated $88.6K and bringing the position to 48,190 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #1424.

Jain Global first reported a position in LENZ in Q1 2026 and has held it in 2 quarters since. The position peaked at $340K in Q1 2026. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Jain Global held 48,190 shares of LENZ Therapeutics worth $274K as of Q2 2026.
  • Jain Global bought 10,998 LENZ Therapeutics shares in Q2 2026, an estimated $88.6K.
  • LENZ Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1424 holding.
  • Jain Global first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Jain Global's LENZ Therapeutics position peaked at $340K in Q1 2026.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.